|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00001746 |
Purpose
Genetically inherited heart diseases like hypertrophic cardiomyopathy (HCM) are conditions affecting the heart passed on to family members by abnormalities in genetic information. These conditions are responsible for many heart related deaths and illnesses.
Presently, there are several research studies being conducted in order to improve the understanding of disease processes and symptoms associated with genetically inherited heart diseases.
This study is designed to determine the eligibility of patients diagnosed with or suspected to have inherited heart disease to participate in these research studies.
| Condition |
|
Heart Disease Hypertrophic Cardiomyopathy |
| MedlinePlus related topics: | Cardiomyopathy Heart Diseases |
| Study Type: | Observational |
| Official Title: | Evaluation of Patients With Known or Suspected Inherited Heart Disease (Screening Protocol) |
| Study Start Date: | April 1998 |
| Estimated Study Completion Date: | April 2003 |
Patients with hypertrophic cardiomyopathy (HCM) and other inherited cardiac diseases are being studied under several research protocols to determine their pathogenesis and clinical manifestations. The purpose of this protocol is to determine the eligibility of patients with known or suspected inherited heart conditions for our research protocols.
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
INCLUSION CRITERIA
Subjects and family members known or suspected to have inherited a cardiac disease such as HCM.
EXCLUSION CRITERIA
Patients with cardiac conditions that are not known to be inherited.
Contacts and Locations
More Information
| Study ID Numbers: | 980102, 98-H-0102 |
| First Received: | November 3, 1999 |
| Last Updated: | March 4, 2008 |
| ClinicalTrials.gov Identifier: | NCT00001746 |
| Health Authority: | United States: Federal Government |
|
|
|
|